Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam flag Vietnam · Delayed Price · Currency is VND
18,400
0.00 (0.00%)
At close: Oct 30, 2026

HNX:MED Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Net Income
25,95215,83315,24711,7446,3663,747
Depreciation & Amortization
6,7497,1697,9168,44410,0209,536
Other Amortization
9.287.43----
Loss (Gain) From Sale of Assets
---773.89-6,395-3,782-3,902
Other Operating Activities
330.751,5722,015-1,9361,683-2,016
Change in Accounts Receivable
11,19727,76023,26137,5082,06358,829
Change in Inventory
2,474-5,67015,425-1,583-14,6644,843
Change in Accounts Payable
464.31-51,176-16,803-95,35126,049-6,766
Change in Other Net Operating Assets
-19,015-873.161,3683,660-1,503-2,160
Operating Cash Flow
28,162-5,37747,653-43,90826,23162,110
Operating Cash Flow Growth
-----57.77%-30.49%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Capital Expenditures
-8,382-9,767-9,979-40,594-117,270-54,364
Sale of Property, Plant & Equipment
---43.64240.21992.27
Investment in Securities
-7,9295,3008,00072,400-44,0006,000
Other Investing Activities
668.45510.861,1217,2043,3543,479
Investing Cash Flow
-15,642-3,956-858.4239,054-157,676-43,893

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Short-Term Debt Issued
-133,282157,753193,594205,142180,305
Total Debt Issued
112,177133,282157,753193,594205,142180,305
Short-Term Debt Repaid
--127,155-194,430-219,966-182,973-192,316
Total Debt Repaid
-128,292-127,155-194,430-219,966-182,973-192,316
Net Debt Issued (Repaid)
-16,1156,127-36,676-26,37222,168-12,012
Issuance of Common Stock
----153,104-
Common Dividends Paid
-5,154-14,997-11,021-6,426-8,816-13,281
Financing Cash Flow
-21,268-8,870-47,697-32,799166,456-25,293

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
39.54-7.45-19.532.9-28.96-
Net Cash Flow
-8,709-18,210-922.47-37,65034,983-7,076

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Free Cash Flow
19,780-15,14437,674-84,502-91,0397,746
Free Cash Flow Growth
------87.20%
Free Cash Flow Margin
4.55%-4.13%8.50%-20.98%-22.70%2.25%
Free Cash Flow Per Share
1593.51-1220.283035.74-6809.19-9696.321234.13
Levered Free Cash Flow
26,535-18,42729,827-101,170-115,88114,442
Unlevered Free Cash Flow
28,374-16,98032,195-97,798-112,75416,703

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Cash Interest Paid
2,8772,3113,8165,4324,9533,643
Cash Income Tax Paid
6,1263,3993,8744,719272.582,383
Change in Working Capital
-4,879-29,95923,250-55,76511,94554,746